We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.5B
AUM Growth
+$1.76B
(+5.4%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
1,963
New
176
Increased
1,051
Reduced
620
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$68.7M |
| 2 |
GE HealthCare
GEHC
|
+$28.6M |
| 3 |
ON Semiconductor
ON
|
+$28.1M |
| 4 |
Caterpillar
CAT
|
+$22.6M |
| 5 |
IBM
IBM
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$94.9M |
| 2 |
Apple
AAPL
|
+$91M |
| 3 |
West Pharmaceutical
WST
|
+$69M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$61.8M |
| 5 |
Amazon
AMZN
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Industrials | 12.05% |
| 3 | Consumer Staples | 10.74% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Liberty Energy
LBRT
$2.83B
| $297K | ﹤0.01% |
22,251
+6,411
| +40% | +$83.1K |
|
1277
Protagonist Therapeutics
PTGX
$8.75B
| $297K | ﹤0.01% |
10,755
+1,869
| +21% | +$46.8K |
|
|
DOOR
1278
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $296K | ﹤0.01% |
2,892
+272
| +10% | +$25.5K |
|
1279
National Vision
EYE
$1.6B
| $295K | ﹤0.01% |
12,146
+757
| +7% | +$17.6K |
|
1280
CRISPR Therapeutics
CRSP
$4.58B
| $295K | ﹤0.01% |
5,254
-556
| -10% | -$31.5K |
|
|
SIX
1281
DELISTED
Six Flags Entertainment Corp.
SIX
| $295K | ﹤0.01% |
+11,336
| New | +$293K |
|
1282
Green Plains
GPRE
$1.19B
| $294K | ﹤0.01% |
9,123
+1,171
| +15% | +$37.1K |
|
1283
Oceaneering
OII
$5.25B
| $294K | ﹤0.01% |
15,709
+1,201
| +8% | +$20.7K |
|
1284
Privia Health
PRVA
$3.21B
| $294K | ﹤0.01% |
+11,247
| New | +$297K |
|
1285
Microvision
MVIS
$88.2M
| $294K | ﹤0.01% |
64,090
-8,059
| -11% | -$28.2K |
|
1286
Minerals Technologies
MTX
$2.31B
| $293K | ﹤0.01% |
5,086
+384
| +8% | +$22.4K |
|
1287
Immunovant
IMVT
$8.09B
| $293K | ﹤0.01% |
15,455
+1,193
| +8% | +$22.2K |
|
1288
Albertsons Companies
ACI
$5.4B
| $293K | ﹤0.01% |
13,433
| – | – |
|
1289
Vontier
VNT
$4.33B
| $293K | ﹤0.01% |
9,091
-46,587
| -84% | -$1.34M |
|
1290
Iovance Biotherapeutics
IOVA
$2.23B
| $293K | ﹤0.01% |
41,579
+8,287
| +25% | +$59.3K |
|
1291
Gentherm
THRM
$1.31B
| $292K | ﹤0.01% |
5,173
+367
| +8% | +$21.1K |
|
1292
XPEL
XPEL
$1.18B
| $291K | ﹤0.01% |
3,455
+384
| +13% | +$28.4K |
|
1293
OSI Systems
OSIS
$3.57B
| $291K | ﹤0.01% |
2,469
+156
| +7% | +$17.9K |
|
1294
Seacoast Banking Corp of Florida
SBCF
$3.26B
| $291K | ﹤0.01% |
13,151
+2,375
| +22% | +$51.6K |
|
1295
United Parks & Resorts
PRKS
$2.11B
| $291K | ﹤0.01% |
5,188
+510
| +11% | +$28.8K |
|
1296
Red Rock Resorts
RRR
$3.74B
| $290K | ﹤0.01% |
6,196
+225
| +4% | +$10.5K |
|
1297
Braze
BRZE
$2.45B
| $290K | ﹤0.01% |
+6,616
| New | +$225K |
|
1298
Legend Biotech
LEGN
$4.3B
| $289K | ﹤0.01% |
4,193
-299
| -7% | -$19.5K |
|
1299
Zentalis Pharmaceuticals
ZNTL
$308M
| $289K | ﹤0.01% |
+10,237
| New | +$246K |
|
1300
Abercrombie & Fitch
ANF
$4.17B
| $289K | ﹤0.01% |
+7,661
| New | +$218K |
|
Similar funds
ProShare Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ProShare Advisors held 1,963 positions worth $34.5B, up 5.4% from $32.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors's Q2 2023 filing shows 176 new, 1,051 increased, 620 reduced and 112 closed positions. Its largest new stake was Artesian Resources: 162,581 shares worth $7.68M. The largest sale was Microsoft, an estimated $94.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q2 2023 buy was Artesian Resources: 162,581 shares worth $7.68M.
- ProShare Advisors added most to Albemarle in Q2 2023, an estimated $68.7M increase.
- ProShare Advisors's biggest Q2 2023 reduction was Microsoft, cutting an estimated $94.9M.
- ProShare Advisors fully exited Rivian in Q2 2023, selling an estimated $11.9M.
- ProShare Advisors's ten largest holdings make up 27% of its $34.5B portfolio in Q2 2023.
- ProShare Advisors opened 176 new positions and closed 112 in Q2 2023.
- ProShare Advisors's portfolio value rose 5.4% quarter-over-quarter to $34.5B.
Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.